A systematic review and meta-analysis of the effect of resistance exercise therapy on the prognosis of patients after percutaneous coronary intervention

被引:6
|
作者
Qiu, Xiaoying [1 ]
Qin, Yuelan [2 ]
Zheng, Zhaofen [1 ]
Li, Lihua [1 ]
Zhang, Yan [1 ]
Wu, Juan [1 ]
He, Peiqin [3 ]
Shi, Zeya [4 ]
机构
[1] Hunan Prov Peoples Hosp, Dept Cardiovasc Med, Changsha, Peoples R China
[2] Hunan Prov Peoples Hosp, Dept Nursing, Changsha, Peoples R China
[3] Guangdong Women & Childrens Hosp, Dept Pediat, Guangzhou, Peoples R China
[4] Hunan Prov Peoples Hosp, Dept Nursing Teaching & Res Off, 89 Guhan Rd, Changsha 410016, Peoples R China
关键词
Resistance exercise; percutaneous coronary intervention (PCI); rehabilitation effect; meta-analysis; CARDIAC REHABILITATION; ARTERY-DISEASE; CAPACITY; STRENGTH;
D O I
10.21037/apm-21-3048
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Exercise rehabilitation therapy after percutaneous coronary intervention (PCI) can accelerate physical recovery, improve cardiovascular work efficiency, and reduce the incidence of arterial restenosis. This study aimed to investigate the effect of resistance exercise therapy after PCI by literature search and meta-analysis. Methods: The databases of Embase, Cochrane library, PubMed, and Ovid were searched for all published English language articles related to resistance exercise after PCI from January 2000 to January 2021. After screening the literature according to the inclusion and exclusion criteria and assessing the risk of bias, RevMan 5.4 software was used to analyze and obtain a forest plot and funnel plot. Results: A total of 7 articles were included in this study for quantitative analysis, involving 776 patients all together. Meta-analysis showed that compared with conventional intervention methods, resistance exercise could reduce the maximum exercise load after PCI [mean difference (MD) =-25.27, 95% confidence interval (CI): -31.97 to -18.57, Z=7.39, P<0.00001], reduce the peak oxygen consumption of exercise after PCI (MD =-2.36, 95% CI: -3.09 to -1.64, Z=6.42, P<0.00001), increase left ventricular ejection fraction (LVEF; MD =4.06, 95% CI: 0.72 to 7.40, Z=2.38, P=0.02), increase the 6-minute walk distance (6MWD; MD =18.23, 95% CI: 0.22 to 36.23, Z=1.98, P=0.05), and improve the quality of life of patients after surgery (MD =5.81, 95% CI: 1.49 to 10.14, Z=2.63, P=0.008). Discussion: Resistance training can improve the physical activity, cardiac function, and quality of life of patients after PCI.
引用
收藏
页码:11970 / 11979
页数:10
相关论文
共 50 条
  • [21] Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    Galli, Mattia
    Benenati, Stefano
    Capodanno, Davide
    Franchi, Francesco
    Rollini, Fabiana
    D'Amario, Domenico
    Porto, Italo
    Angiolillo, Dominick J.
    LANCET, 2021, 397 (10283): : 1470 - 1483
  • [22] Atorvastatin before percutaneous coronary intervention: A systematic review and meta-analysis
    Garcia-Campa, Mariano
    Flores-Ramirez, Ramiro
    Rojo-Garza, Sabrina
    Carrizales-Sepulveda, Edgar Francisco
    Regalado-Ceballos, Diego
    Reyes-Araiza, Raul
    alvarez-Villalobos, Neri
    Rodriguez-Gutierrez, Rene
    Azpiri-Lopez, Jose Ramon
    PLOS ONE, 2024, 19 (01):
  • [23] Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis
    Park, Dae Yong
    Wang, Peter
    An, Seokyung
    Grimshaw, Alyssa A.
    Frampton, Jennifer
    Ohman, E. Magnus
    V. Rao, Sunil
    Nanna, Michael G.
    AMERICAN HEART JOURNAL, 2022, 251 : 101 - 114
  • [24] Effects of Exercise-Based Cardiac Rehabilitation on Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Bao, Xuedan
    Hong, Weiwei
    Feng, Liyao
    HEART SURGERY FORUM, 2024, 27 (07): : E828 - E837
  • [25] Duration of Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Diabetes: A Systematic Review and Meta-analysis
    Apostolos, Anastasios
    Travlos, Christofer
    Tsioulos, Georgios
    Chlorogiannis, Dimitrios-David
    Karanasos, Antonios
    Papafaklis, Michail
    Alexopoulos, Dimitrios
    Toutouzas, Konstantinos
    Davlouros, Periklis
    Tsigkas, Grigorios
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (01) : 64 - 72
  • [26] Omission of aspirin in patients taking oral anticoagulation after percutaneous coronary intervention: a systematic review and meta-analysis
    Zhang, Jian
    Wang, Zheng
    Sang, Wentao
    Wei, Maozeng
    Xu, Feng
    Chen, Yuguo
    CORONARY ARTERY DISEASE, 2019, 30 (02) : 109 - 115
  • [27] The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease A protocol for systematic review and meta-analysis
    Hou, Yi
    Li, Xuhao
    Wang, Xingxin
    Dong, Tiantian
    Yang, Jiguo
    MEDICINE, 2022, 101 (04) : E28677
  • [28] Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention A protocol for a systematic review and network meta-analysis
    Zhu, Zehao
    Wang, Yuanping
    Liao, Weilin
    Li, Huimin
    Wang, Dawei
    MEDICINE, 2018, 97 (24)
  • [29] Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
    Bainey, Kevin R.
    Marquis-Gravel, Guillaume
    Macdonald, Blair J.
    Bewick, David
    Yan, Andrew
    Turgeon, Ricky D.
    PLOS ONE, 2023, 18 (09):
  • [30] Clinical Outcomes of Prolonged Antiplatelet Therapy after Percutaneous Coronary Intervention in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
    Zhang, Jialing
    Li, Han
    Wang, Shixiang
    BLOOD PURIFICATION, 2023, 52 (03) : 255 - 263